Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-15

Clinical Trial Update: Statin and Angiotensin-converting Enzyme Inhibitor on Symptoms in Patients With SCAD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing statin and ACE inhibitor effects on symptoms in spontaneous coronary artery dissection (SCAD) patients; the study status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiotensin-converting enzyme inhibitor (angiotensin-converting enzyme inhibitor)
  • Statin (statin)

Snippet

Sponsor: Cardiology Research UBC | Conditions: Coronary Artery Dissection, Spontaneous | Phase 4 | Status: TERMINATED